Trials / Sponsors / SolAeroMed Inc.
SolAeroMed Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Suspended | Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia Covid19, SARS-CoV-2 Infection | Phase 2 | 2021-09-15 |
| Unknown | Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms. Post Acute COVID-19 Syndrome, Long COVID, COVID-19 Respiratory Infection | Phase 2 | 2021-09-01 |
| Unknown | Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis Cystic Fibrosis, Bronchiectasis | Phase 2 | 2019-08-08 |
| Completed | Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma Asthma | Phase 2 | 2015-02-06 |
| Completed | Phase1, Placebo-Controlled, Randomized, Double-blind, Single-ascending Dose Study in Healthy Subjects. Asthma | Phase 1 | 2014-03-01 |